Fast vs. ultraslow thrombolytic infusion regimens in patients with obstructive mechanical prosthetic valve thrombosis: a pilot randomized clinical trial
Authors:
- Parham SadeghipourPSParham Sadeghipour
- Sedigheh SaediSSSedigheh Saedi
- Leila SaneeiLSLeila Saneei
- Farnaz RafieeFRFarnaz Rafiee
- Siamak YoosefiSYSiamak Yoosefi
- Mozhgan ParsaeeMPMozhgan Parsaee
- Rashide SiamiRSRashide Siami
- Milad SaberiMSMilad Saberi
- Hamidreza PouraliakbarHPHamidreza Pouraliakbar
- Behshid GhadrdoostBGBehshid Ghadrdoost
- Hooman BakhshandehHBHooman Bakhshandeh
- Mohammad Mehdi PeighambariMPMohammad Mehdi Peighambari
- 4 December 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Pharmacotherapy
- Vol. 8 (7) , 668-676
Abstract
Thrombolysis is an alternative to surgery for mechanical prosthetic valve thrombosis (MPVT). Randomized clinical trials have yet to test safety and efficacy of a proposed ultraslow thrombolytic infusion regimen. This single-center, open-label, pilot randomized clinical trial randomized adult patients with acute obstructive MPVT to an ultraslow thrombolytic regimen (25 mg of recombinant tissue-type plasminogen activator [rtPA] infused in 25h) and a fast thrombolytic regimen (50 mg of rtPA infused in 6h). If thrombolysis failed, a repeated dose of 25 mg of rtPA for 6h was administered in both groups up to a cumulative dose of 150 mg or the occurrence of a complication. Primary outcome was a complete MPVT resolution (>75% fall in the obstructive gradient by transthoracic echocardiography, P = 0.34). One case of transient ischemic attack and 3 cases of intracranial hemorrhage (absolute risk difference, −12.5%; 95% CI, −23.1% to −1.0%; P = 0.04). were observed only in the fast-regimen group. The ultraslow thrombolytic regimen conferred a high thrombosis resolution rate without major complications. Such findings should be replicated in more adequately powered trials (IRCT20181022041406N2).Keywords
This publication has 12 references indexed in Scilit:
- Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trialAmerican Heart Journal, 2015
- Treatment of Prosthetic Valve Thrombosis: Current Evidence and Future DirectionsJournal of Clinical Medicine Research, 2015
- Fibrinolytic Therapy for Mechanical Pulmonary Valve ThrombosisPediatric Cardiology, 2014
- Comparison of Thrombolysis Versus Surgery as a First Line Therapy for Prosthetic Heart Valve ThrombosisThe American Journal of Cardiology, 2011
- Accelerated Infusion of Streptokinase for the Treatment of Left-Sided Prosthetic Valve ThrombosisCirculation, 2009
- Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerationsHeart, 2006
- Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patientsJournal of Thrombosis and Thrombolysis, 2006
- Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registryJACC, 2004
- Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiographyJACC, 2000
- Guidelines for Management of Left-Sided Prosthetic Valve Thrombosis: A Role for Thrombolytic Therapy 11These guidelines are the results of a Consensus Conference held during the Symposium on Prosthetic Valve Thrombosis on September 16, 1994, in Budapest, Hungary.JACC, 1997